Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

GLOBAL MARKETS-Stock indexes gain with oil; biotech shares rebound

Published 2015-10-07, 02:47 p/m
© Reuters.  GLOBAL MARKETS-Stock indexes gain with oil; biotech shares rebound
US500
-
DJI
-
ADBE
-
DX
-
LCO
-
CL
-
IXIC
-
NBI
-
US10YT=X
-
0593xq
-
FTEU3
-
MIWD00000PUS
-
DXY
-

* Wall Street up in afternoon trading
* Samsung helps lift Asian shares to 7-week highs
* Dollar gains vs euro and Swiss franc
* Bank of Japan holds off on fresh stimulus

(Updates to U.S. afternoon trading)
By Caroline Valetkevitch
NEW YORK, Oct 7 (Reuters) - World stock indexes edged higher
on Wednesday with a rebound in biotech shares boosting U.S.
equities and as oil prices resumed an upward move in volatile
trading.
U.S. stocks rose modestly, but concern about corporate
earnings just ahead of the third-quarter reporting season kept a
lid on optimism. Reduced profit forecasts from Adobe ADBE.O
and Yum Brands YUM.N added to gloom about the earnings
picture.
Oil prices struggled to extend their recent rally as U.S.
government data showed domestic crude inventories rose 3.1
million barrels last week, more than forecast.
The U.S. dollar rose against the euro and the Swiss franc,
while the yen gained against the dollar after the Bank of Japan
left monetary policy unchanged. ID:nL1N12713A The dollar index
.DXY was up 0.1 percent.
Although the Bank of Japan held off on expanding stimulus on
Wednesday, expectations of more support rather than less are
growing as worries mount over a global economic slowdown. This
week, the International Monetary Fund again cut its growth
forecast.
The potential for more stimulus from the European Central
Bank and Bank of Japan has contributed to a backdrop of
accommodative central bank policy, along with expectations that
a Federal Reserve rate increase will remain on hold until 2016.
On Wall Street, the S&P 500 health care index .SPXHC was
up 1.3 percent, in the biggest boost to the S&P 500, while the
Nasdaq Biotech index .NBI was up 1.9 percent, after recent
steep losses.
The Dow Jones industrial average .DJI rose 69.95 points,
or 0.42 percent, to 16,860.14, the S&P 500 .SPX gained 10.06
points, or 0.51 percent, to 1,989.98 and the Nasdaq Composite
.IXIC added 25.29 points, or 0.53 percent, to 4,773.65.
Shares of Adobe were down 6 percent at $80.05.
"Tech investors are very worried heading into earnings season
and this has been an overhang with many of the tech stalwarts
having a bullseye on their back," said Daniel Ives, senior
analyst at FBR Capital.
Analysts have been cutting forecasts for U.S. third-quarter
earnings since the start of the quarter.
But even as Citi strategists have warned that analyst
earnings forecasts are too optimistic, they have backed the view
that the bull market has yet to die, predicting global equities
will rise 20 percent through to the end of 2016. The market is
"already pricing in" a gloomier scenario, they argue.
The pan-European FTSEurofirst 300 .FTEU3 closed up 0.1
percent, while MSCI's all-country world stock index
.MIWD00000PUS was up 0.8 percent.
Asian shares reached a seven-week high. South Korea's
Samsung Electronics (KS:005930) 005930.SS helped sentiment when it
reported an estimated quarterly profit that exceeded analyst
expectations.
Brent LCOc1, the global crude benchmark, was up 25 cents
at $52.17 a barrel by 12:22 p.m. (1622 GMT). At its session
high, Brent was up more than $1. It turned negative before then
edging higher.
The West Texas Intermediate (WTI) benchmark for U.S. crude
CLc1 was down 5 cents to $48.48 a barrel. It had also been up
more than $1 at its session high.
U.S. Treasuries prices fell. Benchmark 10-year Treasuries
US10YT=RR were down 10/32 in price to yield 2.072 percent, up
almost 4 basis points from late Tuesday.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.